What You Should Know
- Mass General Brigham announced the launch of two clinical trials to evaluate acute, hospital-level care delivered in the home for patients living with dementia and those experiencing primary psychiatric conditions.
- The dementia trial, funded by the National Institute on Aging (NIA), is a randomized controlled study enrolling 200 patients followed for one year; it evaluates whether proactive care planning, virtual urgent care, and mobile integrated health paramedics can safely prevent traumatic emergency department visits and inpatient admissions.
- The behavioral health trial, funded by the Thompson Family Foundation, represents the nation’s first clinical study testing an emergency-department-to-home hospital care pathway for primary psychiatric conditions (psychosis, severe depression, anxiety, and behavioral symptoms of dementia) using specialized multidisciplinary teams of psychiatrists, psychiatric nurses, and psychologists.
Mitigating Delirium, Boarding, and Sensory Deconditioning
The trials assess whether mobile integrated health teams and decentralized acute care infrastructure can safely substitute for traditional inpatient hospital admissions in patient populations historically excluded from acute home-care protocols.
While acute Hospital-at-Home programs have become standard across health systems for acute exacerbations of heart failure, COPD, and pneumonia, individuals with cognitive impairment or acute psychiatric episodes have traditionally been admitted to brick-and-mortar facilities. However, the sensory disruption, rigid clinical routines, and ambient noise of standard hospital units frequently exacerbate behavioral symptoms and trigger hospital-acquired delirium in dementia patients. Concurrently, emergency departments face persistent boarding crises due to shortages of inpatient psychiatric beds.
Mass General Brigham is expanding the clinical scope of decentralized acute care through two structured trial methodologies:
- NIA-Funded Dementia Trial (200 Patients): Supported by the National Institute on Aging (NIA), this randomized controlled trial tracks 200 participants longitudinally over 12 months. Patients with moderate-to-severe dementia are randomized to either standard inpatient hospital care or a proactive Home Hospital model combining scheduled in-home care planning, on-demand virtual urgent care, mobile integrated health paramedics, and direct home admission during acute decompensation episodes.
- Thompson Family Foundation Psychiatric Pilot (20 Patients): Evaluates the feasibility, safety, and clinical efficacy of admitting patients presenting to the emergency department with primary psychiatric conditions—including acute psychosis, major depressive episodes, severe anxiety, and dementia-related neuropsychiatric symptoms—directly into acute psychiatric home hospital care.
- Multidisciplinary Mobile Clinical Pods: Deploys specialized care teams consisting of psychiatrists, psychiatric nurses, clinical psychologists, and licensed mental health specialists to manage medical and behavioral stabilization directly in the patient’s residence.
- Inpatient Bed Decompression: Expands MGB’s home-based clinical portfolio (which already encompasses acute medical admissions and home oncology infusions) to alleviate emergency department boarding bottlenecks and free up physical acute-care beds across regional academic medical centers.
Trial Blueprint & Methodology Snapshot
- Trial 1 (Dementia Pathway): 200 Patients | 12-Month Longitudinal Follow-Up | NIA-Funded RCT
- Trial 2 (Behavioral Health Pathway): 20-Patient ED-to-Home Feasibility Pilot | Thompson Family Foundation
- Care Delivery Mechanism: Mobile Integrated Health (MIH) Paramedics + Virtual Urgent Care + Specialized Multidisciplinary Teams
- Target Diagnostic Cohorts: Moderate/Severe Dementia, Acute Psychosis, Major Depression, Severe Behavioral Disturbances
- Primary Operational Endpoints: Delirium Reduction, Avoided Emergency Department Boarding, Hospital Bed Decompression, Caregiver Strain Mitigation
